For those who follow this blog, you know that I am a VERY fortunate pancreatic cancer survivor. Since my cancer was diagnosed early, I was able to have a successful Whipple surgery. For most, the outlook is not as positive.
But, new research presents greater hope for the future. As Erika Edwards reports for NBC News:
“Historically, doctors have given pancreatic cancer patients chemotherapy or radiation hoping it would cause the tumor to shrink or pull away from the artery or vein it’s ensnared. Dr. Mark Truty, a surgical oncologist at Mayo Clinic, believes that’s the wrong approach. ‘You’re going to be sorely disappointed if that’s what you’re expecting’, Truty told NBC News.”
“About a third of pancreatic cancer cases are found at stage 3. Truty estimates about half of his pancreatic cancer patients diagnosed at this stage seek his care after other physicians said their tumors could not be surgically removed. His team’s approach to treating stage 3 pancreatic cancer is different from most other oncology practices”
“The Mayo Clinic approach works like this. Patients are given extended, personalized chemotherapy until levels of a tumor marker in the blood called CA 19-9 fall to a normal range. Then if a PET scan shows the tumor is destroyed, doctors move forward with radiation and surgery.”
“Among 194 pancreatic cancer treated this way at the Mayo Clinic, 89 percent lived longer than the expected 12 to 18 months. The approach has pushed average survival to five years after diagnosis, according to a study by the Mayo Clinic.
To learn more, watch the following video. Note: The beginning of the video may be a downer. But the overall video is hopeful.
